Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity.
- Published Article
- Publication Date
Jan 01, 2002
Drug cost should not be a determining factor in making this treatment choice, as the cost effectiveness ratios are similar for both products.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/12236804